Page last updated: 2024-11-02

phenobarbital and Agenesis of Hemidiaphragm

phenobarbital has been researched along with Agenesis of Hemidiaphragm in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
" A maintenance dose of 5 mg/kg/d provided a peak concentration of 19."1.30Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. ( Buck, ML; Elliott, ES, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, ES1
Buck, ML1

Other Studies

1 other study available for phenobarbital and Agenesis of Hemidiaphragm

ArticleYear
Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:4

    Topics: Anticonvulsants; Extracorporeal Membrane Oxygenation; Hernia, Diaphragmatic; Hernias, Diaphragmatic,

1999